Omada Health (OMDA) CAO Craig Gracey Sells $120K of Stock
Craig Gracey sold 6,894 shares of OMDA on June 12, 2026, in a planned transaction.
Reviewed by automated data checks against the source filing. How we make and check alerts
Craig Gracey, Chief Accounting Officer at Omada Health, Inc. ($OMDA), sold 6,894 shares at an average price of $17.42, worth about $120,093.48, on June 12, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.
Since the trade, $OMDA is up 4.9% after 1 week, up 37.1% after 1 month and up 2.9% to date (from the $17.14 close on Jun 12, 2026).
OMDA
Omada Health, Inc.
Key Points
- On June 12, 2026, OMDA's Chief Accounting Officer Craig Gracey sold 6,894 shares, valued at $120,093.
- OMDA shares traded at $17.33, with peer funds like Divisadero Street Capital significantly increasing their stakes.
- Analysts from Barclays and Citizens maintained buy ratings on OMDA, with targets up to $21.
Get $OMDA trade alerts by text
We text you when insiders, Congress or big funds trade $OMDA. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Omada Health, Inc. alert may contain errors. Disclosures
Craig Gracey, the Chief Accounting Officer at OMDA, sold 6,894 shares of the company on June 12, 2026. The transaction was part of a planned sale, with the shares sold at an average price of $17.42, totaling approximately $120,093.
Other Institutional Activity in OMDA
Divisadero Street Capital Management significantly increased its position in OMDA, adding 5,418,118 shares to hold a total of 5,887,715 shares, valued at about $74.0 million. Revelation Capital Management maintained its position, holding 5,208,034 shares worth approximately $65.5 million. Cigna Investments made a slight adjustment, reducing its stake by just 1 share to 3,444,629 shares, valued at roughly $43.3 million. FMR LLC reduced its holdings by 1,890,124 shares, ending with 3,288,380 shares valued at $41.3 million.
Omada Health, Inc. Stock Down 15.2%
OMDA shares traded around $17.33 recently. The stock has been moving within a 52-week range from a low of $15.00 to a high of $22.00. It currently has a 50-day moving average of $18.00 and a 200-day moving average of $19.50.
Insider Buying and Selling at Omada Health, Inc.
Along with Craig Gracey, other insiders have been active. On June 15, 2026, CFO Steven Cook sold 6,800 shares at $17.23 each. On June 12, 2026, President Wei-Li Shao sold 4,589 shares at $17.24. Earlier, on June 5, CEO Sean Duffy sold 9,450 shares, and President Shao sold 1,843 shares at $17.93. These transactions were a mix of planned and unplanned sales.
Analysts Set New Price Targets
On May 8, 2026, Barclays, Citizens, and Evercore ISI Group maintained their buy ratings for OMDA, with price targets of $20 and $21. Wells Fargo maintained a hold rating with an $18 target. Earlier, on April 14, Citizens initiated coverage with a buy rating and an $18 target.
Bottom Line
Craig Gracey's recent planned sale of OMDA shares is part of regular insider activity. Investors often watch insider transactions for insights, though these actions don't necessarily signal future stock performance. Peer fund movements and analyst ratings also provide context for OMDA's market position.
Related Filing Alerts
Source: Craig Gracey's Form 4 filing on $OMDA (Jun 12, 2026). Find the original filing: OMDA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts